Your browser doesn't support javascript.
loading
A single-center experience using alemtuzumab, fludarabine, melphalan, and thiotepa as conditioning for transplantation in pediatric patients with chronic granulomatous disease.
Bhatt, Sima T; Schulz, Ginny; Hente, Monica; Slater, Ashley; Murray, Lisa; Shenoy, Shalini; Bednarski, Jeffrey J.
Afiliação
  • Bhatt ST; Department of Pediatrics, Washington University in St. Louis, St. Louis, MO.
  • Schulz G; Department of Pediatrics, Washington University in St. Louis, St. Louis, MO.
  • Hente M; Department of Pediatrics, Washington University in St. Louis, St. Louis, MO.
  • Slater A; Department of Pediatrics, Washington University in St. Louis, St. Louis, MO.
  • Murray L; Department of Pediatrics, Washington University in St. Louis, St. Louis, MO.
  • Shenoy S; Department of Pediatrics, Washington University in St. Louis, St. Louis, MO.
  • Bednarski JJ; Department of Pediatrics, Washington University in St. Louis, St. Louis, MO.
Pediatr Blood Cancer ; 67(1): e28030, 2020 01.
Article em En | MEDLINE | ID: mdl-31599480

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vidarabina / Tiotepa / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Alemtuzumab / Doença Enxerto-Hospedeiro / Doença Granulomatosa Crônica / Melfalan Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Child, preschool / Humans / Infant Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vidarabina / Tiotepa / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Alemtuzumab / Doença Enxerto-Hospedeiro / Doença Granulomatosa Crônica / Melfalan Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Child, preschool / Humans / Infant Idioma: En Ano de publicação: 2020 Tipo de documento: Article